ArticlePCN reports : psychiatry and clinical neurosciences2026
A case of tic improvement following tipepidine administration in a boy with Tourette syndrome comorbid with attention-deficit/hyperactivity disorder and autism spectrum disorder.
Article in PCN reports : psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tourette Syndrome (TS) is defined by motor and vocal tics that begin in childhood and persist for over a year. TS causes difficulties in daily life and lowers self-esteem, yet pharmacological treatment options for TS remain limited. Tipepidine, administered in this case report, is generally used as a safe and inexpensive cough suppressant. Recent studies have suggested that tipepidine may improve symptoms of attention-deficit/hyperactivity disorder (ADHD) and depression. Case Presentation: We report the clinical course of a boy with TS, ADHD, and autism spectrum disorder (ASD), in whom the addition of tipepidine to aripiprazole was associated with improvement in both motor and vocal tics. The patient had tried several antipsychotics before he was prescribed tipepidine. However, the effectiveness of those drugs was temporary, and the patient experienced tolerability issues such as drowsiness. The addition of tipepidine was well tolerated, and the improvement in tic symptoms was maintained during long-term follow-up. Conclusion: This case suggests that adjunctive tipepidine may be well tolerated and associated with sustained improvement in motor and vocal tics during long-term follow-up in a patient with TS receiving aripiprazole.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.